Israel - engelsk - Ministry of Health

abic marketing ltd, israel - vinblastine sulfate - solution for injection - vinblastine sulfate 1 mg / 1 ml - vinblastine - vinblastine - vinblastine has proved effective in the treatment of the following neoplasms, either alone or in conjunction with other oncolytic drugs:frequently responsive malignancies :• generalized hodgkin's disease (stages iii and iv, ann arbor modification of rye staging system)• non-hodgkin's lymphoma: - reticulum-cell sarcoma - lymphosarcoma• mycosis fungoides.• neuroblastoma.• histiocytosis x.less frequently responsive malignancies :• choriocarcinoma resistant to other chemotherapeutic agents.• embryonal carcinoma of the testis.• carcinoma of the breast, unresponsive to appropriate endocrine surgery and hormonal therapy.

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alfred e. tiefenbacher gmbh & co. kg - bilastine 20 mg - tablet - 20 mg - bilastine 20 mg - bilastine

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris bv-srl - azelastine hydrochloride 1 mg/ml - nasal spray, solution - 1 mg/ml - azelastine hydrochloride 1 mg/ml - azelastine

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - vinblastine sulfate - solution for injection - 1mg/1ml

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - vinblastine sulfate 1 mg/ml - solution for injection - 1 mg/ml - vinblastine sulfate 1 mg/ml - vinblastine

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

grifols australia pty ltd - alpha-1-proteinase inhibitor, quantity: 1000 mg - diluent, not applicable - excipient ingredients: - prolastin-c is an alpha-1-proteinase inhibitor (human, alpha1-pi) indicated to increase serum alpha1-pi levels in adults with congenital deficiency of alpha-1 antitrypsin and with clinically significant emphysema (fev1 less than 80%). the data for clinical efficacy of prolastin-c is derived from changes in the biomarkers alpha-1 anti-protease level and ct lung density. efficacy on fev1 or patient relevant endpoints such as quality of life or pulmonary exacerbations has not been established in randomised clinical trials. clinical trials have only included patients who were not smoking.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - azelastine hydrochloride, quantity: 0.137 mg/actuation (equivalent: azelastine, qty 0.125 mg/actuation) - spray, nasal - excipient ingredients: dibasic sodium phosphate dodecahydrate; disodium edetate; hypromellose; purified water; citric acid; sodium chloride - for the symptomatic treatment of seasonal allergic rhinitis, perennial allergic rhinitis.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: glycerol; disodium edetate; phenethyl alcohol; purified water; carmellose sodium; microcrystalline cellulose; polysorbate 80; benzalkonium chloride - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: disodium edetate; purified water; glycerol; microcrystalline cellulose; polysorbate 80; phenethyl alcohol; benzalkonium chloride; carmellose sodium - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.

Malta - engelsk - Medicines Authority

bausch + lomb ireland limited 3013 lake drive citywest business campus dublin 24, d24ppt, ireland - azelastine hydrochloride - nasal spray, solution - azelastine hydrochloride 0.14 mg - nasal preparations